# IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

> **NCT02881437** · PHASE4 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 22 (actual)

## Conditions studied

- Primary Immunodeficiency

## Interventions

- **DRUG:** IgHy10

## Key facts

- **NCT ID:** NCT02881437
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-11
- **Primary completion:** 2018-03-16
- **Final completion:** 2018-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881437, "IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02881437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*